The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

Contraline — a trailblazer in the nascent male contraceptive market — released promising new trial data on Thursday showing that the company’s contraceptive hydrogel has demonstrated safety ...

The U.S. health insurance industry — a $1.29 trillion giant — is under strain. Soaring healthcare costs, policy shake-ups, and long-standing access gaps are squeezing not just insurers, but ...

Nourish, a nutrition counseling company, announced Wednesday that it raised $70 million in Series B funding for its network of registered dietitians. New York City-based Nourish, which launched ...

Having the right surgical tools on hand can mean the difference between a routine extraction and a complicated procedure. As a health care professional or decision-maker, knowing the top surgical ...

A cancer drug from partners AstraZeneca and Daiichi Sankyo currently approved as a second-line or later treatment for metastatic breast cancer has interim clinical data showing it helped patients ...

The nursing workforce crisis has improved slightly since the pandemic, but it’s far from over. New research from the National Council of State Boards of Nursing (NCSBN) shows that nurses are ...

Many providers express confidence about their AI strategy, but relatively few have established the governance structures needed to ensure responsible AI deployment, according to new research.

Reliable analytical instruments like spectrometers are essential for advancing health care research and diagnostics. However, budgetary constraints often require cost-effectiveness without ...